Healthcare - Biotechnology - NASDAQ - US
$ 0.037
0 %
$ 453 K
Market Cap
-0.04
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
78.57%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Bellerophon Therapeutics, Inc.
BLPH has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart BLPH
EBIT FORECAST
EBIT Forecast Chart BLPH
NET INCOME FORECAST
Net Income Chart BLPH